Newsbenzinga
Alterity Therapeutics Says ATH434 50 mg Slowed Multiple System Atrophy Decline By About 52% In Post Hoc Phase 2 Analysis
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…